Mandeep Singh Kumar, Shankha Banerjee join NATHEALTH leadership team
New appointments bring diagnostics and medtech expertise to strengthen healthcare delivery and policy engagement
New appointments bring diagnostics and medtech expertise to strengthen healthcare delivery and policy engagement
His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research
India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Gilenya Capsules, 0.5 mg of Novartis Pharmaceuticals Corporation (Novartis)
nSEPIA aims to bring structure to an area long dominated by subjectivity
The move brings one of the country’s most widely prescribed blood thinners onto Cost Plus Drug Company’s online pharmacy platform
The first Phase III and second Phase III trials will be multi-centre, randomised, assessor-blind, active-comparator studies to determine the efficacy, safety and tolerability of orally administered Zintrodiazine
Collaboration to drive diagnostics exports, tap high-growth regional markets and build scalable commercialization platform
New plan integrates critical illness protection, market-linked health fund and preventive care platform for holistic financial and health security
Subscribe To Our Newsletter & Stay Updated